Learn more about whether BioCryst Pharmaceuticals, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Viridian Therapeutics, Inc.’s VRDN share price has dipped by 5.15%, which has investors questioning if this is right time to buy.

GSK stock dips 0.6% after six-session gain streak. EU panel backs Blenrep for multiple myeloma, while FDA expands asthma ...

International Student Insurance (ISI) is proud to announce the relaunch of its Emotional and Mental Health Awareness Training Program for International Students, now redesigned and updated for today's ...

Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a ...

Merck's ( NYSE: MRK) experimental antibody drug conjugate zilovertamab vedotin, in combination with standard of care, ...

Innovative antibody drug conjugates are advancing in ovarian cancer treatment, exploring new maintenance therapies and ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional ...